Practical Use of Early Stage Health Technology Assessment of Medical Devices: Systematic Literature Review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F20%3A00332863" target="_blank" >RIV/68407700:21460/20:00332863 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1007/978-3-030-31635-8_127" target="_blank" >http://dx.doi.org/10.1007/978-3-030-31635-8_127</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-3-030-31635-8_127" target="_blank" >10.1007/978-3-030-31635-8_127</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Practical Use of Early Stage Health Technology Assessment of Medical Devices: Systematic Literature Review

Popis výsledku v původním jazyce

The early stage HTA (eHTA) is a commonly used tool for identifying economic indicators of health technology in early phases of research and development. It provides powerful influence instruments to manage the manufacturer’s investment risks and to improve the device design. There is no uniform generally accepted standard of eHTA implementation, but an analysis of several largescale theoretical studies showed that, in general, the eHTA process for medical devices consists of three stages: conceptual modelling of the new medical technology, determination of new technology parameters by expert elicitation methods, and simulation allowing for an analysis of commercial options. The aim of this study is a systematic review of studies published from 2014 till 2019 and an analysis of selected articles in terms of the methods used in each step of the early stage health technology assessment. Most of the analyzed case studies deal only with a part of the early stage medical device assessment, probably because of its confidential character. But we have found the popularity of decision-making models, the applicability of AHP (the analytic hierarchy process) methods to the elicitation process, and information on the use of CEA (cost-effectiveness analysis) methods and headroom methods as economic analysis tools.

Název v anglickém jazyce

Practical Use of Early Stage Health Technology Assessment of Medical Devices: Systematic Literature Review

Popis výsledku anglicky

The early stage HTA (eHTA) is a commonly used tool for identifying economic indicators of health technology in early phases of research and development. It provides powerful influence instruments to manage the manufacturer’s investment risks and to improve the device design. There is no uniform generally accepted standard of eHTA implementation, but an analysis of several largescale theoretical studies showed that, in general, the eHTA process for medical devices consists of three stages: conceptual modelling of the new medical technology, determination of new technology parameters by expert elicitation methods, and simulation allowing for an analysis of commercial options. The aim of this study is a systematic review of studies published from 2014 till 2019 and an analysis of selected articles in terms of the methods used in each step of the early stage health technology assessment. Most of the analyzed case studies deal only with a part of the early stage medical device assessment, probably because of its confidential character. But we have found the popularity of decision-making models, the applicability of AHP (the analytic hierarchy process) methods to the elicitation process, and information on the use of CEA (cost-effectiveness analysis) methods and headroom methods as economic analysis tools.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

20601 - Medical engineering

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

XV Mediterranean Conference on Medical and Biological Engineering and Computing MEDICON 2019

ISBN

978-3-030-31634-1

ISSN

—

e-ISSN

1680-0737

Počet stran výsledku

10

Strana od-do

1047-1056

Název nakladatele

Springer Nature Switzerland AG

Místo vydání

Basel

Místo konání akce

Coimbra

Datum konání akce

26. 9. 2019

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

000582693600127